Companies › OMER

OMEROS (OMER)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001285819 · EDGAR filings · Updated 2026-07-24

OMEROS (OMER) has reported institutional ownership of 42.8%, with 160 institutional managers holding positions valued at $325.9M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-06 — Current report (8-K) filed
• 2026-06-25 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OMEROS has 160 institutional holders and institutional ownership of 42.8%.

Insider activity

Insiders reported 8 transactions (0 buys, 2 sells) across 2 reporting insiders, with a net reported value of −$750.9K.

Data flags from SEC filings

Related companies

TENAX THERAPEUTICS INC (TENX) · ENANTA PHARMACEUTICALS INC (ENTA) · PERSPECTIVE THERAPEUTICS INC (CATX) · ATEA PHARMACEUTICALS INC (AVIR) · ENTRADA THERAPEUTICS INC (TRDA) · VANDA PHARMACEUTICALS INC (VNDA)